Tirzepatide to Help People Quit Smoking
Treatments studied
Part of Mental health clinical trials.
This study tests whether tirzepatide, a medication that helps with weight and blood sugar, can also help people quit smoking. You'd receive the medication plus standard quitting support (nicotine patches or gum and a quit-smoking app) over several months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 21 and 65 years old
- Have a BMI of 25 or higher (a measure of body weight relative to height)
- Smoke at least 10 cigarettes daily for the past 6 months, with more than 2 years of smoking history
- Be ready to try quitting within the next 30–60 days
- Able to attend weekly clinic visits for the full study duration
- Willing to use nicotine replacement (patches or gum) and a quit-smoking app alongside the study medication
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called tirzepatide (a once-weekly injection) can help people reduce their alcohol consumption. It is for people who drink heavily, have a high BMI, and are actively seeking help to drink less.
This study tests whether tirzepatide, a medication that may help reduce cravings and weight, can help people who use methamphetamine cut down or stop. It aims to find a new treatment option for methamphetamine use disorder.
This study tests a medication called tirzepatide (a once-weekly injection) to help teenagers with obesity and related health conditions lose weight. It aims to see if the drug is safe and effective for this age group.
This trial tests a medication called tirzepatide (which can help with weight loss) combined with talking therapy (cognitive-behavioural therapy) to help people reduce or stop drinking alcohol while also losing weight. It may be a good fit if you're overweight and want to change your drinking habits.
This trial tests whether tirzepatide, a medicine used for type 2 diabetes and weight loss, can help people with severe cannabis use disorder cut down or quit. It may reduce cravings and other symptoms of withdrawal.
This study tests a medicine called tirzepatide to see if it helps people with overweight or obesity lose weight, whether or not they also have type 2 diabetes. Tirzepatide is given as an injection and works on hormones that control appetite.
Hear when a new Smoking Cessation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.